症状性慢性硬膜下血肿钻孔引流术后6、12或24小时引流(DRAIN-TIME 2):全国随机对照试验研究方案
DRAIN-TIME 2是丹麦多中心随机对照试验,纳入全国四个神经外科科室的慢性硬膜下血肿患者,随机分配至术后6、12或24小时被动硬膜下引流,主要终点为90天血肿复发率。该方案旨在探索不增加复发率的最短引流时间,以减少引流相关并发症和住院时间。
要点
- 慢性硬膜下血肿钻孔引流术后复发率为5-20%,症状性患者需再手术。
- 术后最长48小时硬膜下引流可有效降低复发血肿,但最短有效引流时间未知。
- DRAIN-TIME 2随机分配6、12或24小时被动引流,主要终点为90天复发率。
核心结论
- 该多中心试验将提供关于不增加复发率的最短可能引流时间的证据。
- 作者认为较短引流期可能与较少的引流相关并发症、较少的制动相关并发症及较短住院时间相关,从而减轻该疾病的整体医疗服务负担。
研究设计与样本
- DRAIN-TIME 2是丹麦多中心随机对照试验,包括丹麦全部四个神经外科科室。
- 纳入年龄大于18岁、无其他颅内病变或既往脑手术史的患者,在入院时或术后不晚于6小时招募。
- 每例患者随机分配至单孔钻孔清除慢性硬膜下血肿后6、12或24小时被动硬膜下引流。
- 精神能力正常的患者被要求完成SF-36问卷;无行为能力和精神能力正常的患者均被纳入。
主要发现
- 慢性硬膜下血肿复发率为5-20%,症状性患者需再手术,有时需反复手术。
- 术后最长48小时硬膜下引流可有效减少复发血肿。
- 不增加复发率的最短可能引流时间未知。
- 主要终点为90天慢性硬膜下血肿复发率。
- 次要结局包括90天SF-36、住院时间、引流相关并发症、制动相关并发症和死亡率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic subdural hematoma (CSDH) is a common acute or subacute neurosurgical condition, typically treated by burr-hole evacuation and drainage. Recurrent CSDH occurs in 5-20% of cases and requires reoperation in symptomatic patients, sometimes repeatedly. Postoperative subdural drainage of maximal 48 h is effective in reducing recurrent hematomas. However, the shortest possible drainage time without increasing the recurrence rate is unknown. METHODS: DRAIN-TIME 2 is a Danish multi-center, randomized controlled trial of postoperative drainage time including all four neurosurgical departments in Denmark. Both incapacitated and mentally competent patients are enrolled. Patients older than 18 years, free of other intracranial pathologies or history of previous brain surgery, are recruited at the time of admission or no later than 6 h after surgery. Each patient is randomized to either 6, 12, or 24 h of passive subdural drainage following single burr-hole evacuation of a CSDH. Mentally competent patients are asked to complete the SF-36 questionnaire. The primary endpoint is CSDH recurrence rate at 90 days. Secondary outcome measures include SF-36 at 90 days, length of hospital stay, drain-related complications, and complications related to immobilization and mortality. DISCUSSION: This multi-center trial will provide evidence regarding the shortest possible drainage time without increasing the recurrence rate. The potential impact of this study is significant as we believe that a shorter drainage period may be associated with fewer drain-related complications, fewer complications related to immobilization, and shorter hospital stays-thus reducing the overall health service burden from this condition. The expected benefits for patients' lives and health costs will increase as the CSDH patient population grows. TRIAL REGISTRATION: ISRCTN Registry ISRCTN15186366 . Registered in December 2020 and updated in October 2021. This protocol was developed in accordance with the SPIRIT Checklist and by use of the structured study protocol template provided by BMC Trials.
引用
- Grønhøj MH, Jensen TSR, Sindby AK, et al. Postoperative drainage for 6, 12, or 24 h after burr-hole evacuation of chronic subdural hematoma in symptomatic patients (DRAIN-TIME 2): study protocol for a nationwide randomized controlled trial. Trials. 2022. PMID: 35287694. doi:10.1186/s13063-022-06150-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。